Cargando…

PB2197: ADULT LANGERHANS CELL HISTIOCYTOSIS WITH LIVER INVOLVEMENT

Detalles Bibliográficos
Autores principales:	Chang, Long, Cai, Hua-Cong, Luo, Ya-Ping, Lang, Min, Lin, He, Duan, Minghui, LI, Jian, Zhou, Dao-Bin, Cao, Xin-Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429602/ http://dx.doi.org/10.1097/01.HS9.0000975540.39927.25

Ejemplares similares

PB1808: LANGERHANS CELL HISTIOCYTOSIS IN ADOLESCENT PATIENTS: A SINGLE-CENTER RETROSPECTIVE STUDY
por: Cai, H., et al.
Publicado: (2022)

PB2197: PRE-HAEMATOPOIETIC STEM CELL TRANSPLANT DENTAL ASSESSMENT: A SERVICE EVALUATION
por: Wali, R., et al.
Publicado: (2022)

PB1937: A RARE, DIFFICULT- TO- DIAGNOSE DISEASE; LANGERHANS CELL HISTIOCYTOSIS – A SINGLE CENTRE EXPERIENCE
por: Tüzün, Betül Kübra, et al.
Publicado: (2023)

PB2222: DOES LUNG LESION SEVERITY AFFECT THE OUTCOME IN PEDIATRIC PULMONARY MULTISYSTEM LANGERHANS CELL HISTIOCYTOSIS?
por: Sedky, Mohamed Sedky, et al.
Publicado: (2023)

PB2491: LANGERHANS CELL HISTIOCYTOSIS (LCH) IN THE MAXILLOFACIAL AREA IN ADULT. COMPLETE REMISSION WITH CLADRIBINE. CASE REPORT AND REVIEW.
por: De Miguel Llorente, Dunia, et al.
Publicado: (2023)

PB2226: HIGH RISK LANGERHANS CELL HISTIOCYTOSIS (LCH) IN CHILDREN: THE ROLE OF CLADRIBINE SALVAGE IN IMPROVING THE OUTCOME. A SINGLE CENTER EXPERIENCE
por: Sedky, Mohamed Sedky, et al.
Publicado: (2023)

PB2181: CLINICAL FEATURES, TREATMENT APPROACHES, AND OUTCOMES IN ROSAI-DORFMAN DISEASE: A RETROSPECTIVE ANALYSIS OF 104 PATIENTS
por: Chang, Long, et al.
Publicado: (2023)

PB2075: CRYSTAL STORING HISTIOCYTOSIS PRESENTING AS HEAD AND NECK TUMORS
por: De La Flor Weiss, E. P., et al.
Publicado: (2022)

PB2213: RETROSPECTIVE ANALYSIS OF 45 UNSELECTED PATIENTS WITH HISTIOCYTOSIS CONFIRMS PROGNOSTIC RELEVANCE OF ORGAN INVOLVEMENT: SINGLE‐CENTER EXPERIENCE
por: Yilmaz, Hulya, et al.
Publicado: (2023)

Clinical features, genomic profiling, and outcomes of adult patients with unifocal Langerhans cell histiocytosis
por: Lang, Min, et al.
Publicado: (2023)

Clinical characteristics, genomic profiling and outcomes of single system multifocal Langerhans cell histiocytosis in adults with bone involvement
por: Han, Hong-xiao, et al.
Publicado: (2023)

Langerhans cell histiocytosis in adolescent patients: a single-centre retrospective study
por: Cai, Hua-cong, et al.
Publicado: (2022)

Clinical presentation and prognostic analysis of adult patients with Langerhans cell histiocytosis with pulmonary involvement
por: Miao, Hui-lei, et al.
Publicado: (2020)

P1039: LOW DOSE CYTARABINE FOR ADULT PATIENTS WITH NEWLY DIAGNOSED LANGERHANS CELL HISTIOCYTOSIS: A SINGLE ARM, SINGLE CENTER, PROSPECTIVE PHASE 2 STUDY
por: Chang, Long, et al.
Publicado: (2023)

P544: SINGLE-SYSTEM UNIFOCAL ADULT LANGERHANS CELL HISTIOCYTOSIS: A SINGLE-CENTER RETROSPECTIVE STUDY
por: Lang, Min, et al.
Publicado: (2023)

Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis
por: Liu, Ting, et al.
Publicado: (2022)

PB1721: CD27 EXPRESSION IN CHILDREN WITH B CELL LYMPHOID MALIGNANCIES AND HEMOPHAGOCYTIC LYMPH HISTIOCYTOSIS IN RELATION TO EBV STATUS: A PILOT STUDY
por: Hussien, Nihal, et al.
Publicado: (2023)

PB2639: CHANGES IN PLATELETS IN CHRONIC LIVER DISEASES
por: Nuriddinova, Nodira
Publicado: (2023)

Skeletal involvement in Langerhans cell histiocytosis
por: Khung, Suonita, et al.
Publicado: (2013)

PB1961: INVOLVEMENT OF IMMUNITY IN THE CONTINUATION OF TFR AFTER BOSTINIB DISCONTINUATION
por: Fujioka, Yuki, et al.
Publicado: (2023)

PB1951: PROGNOSTIC SIGNIFICANCE OF CLINICAL INDICATORS RELATED TO AMINO ACID METABOLISM IN CHRONIC LYMPHOCYTIC LEUKEMIA
por: Liu, Ming, et al.
Publicado: (2023)

PB2086: CHRONIC LYMPHOPROLIFERATIVE DISORDER OF NK CELLS WITH LIVER INFILTRATION
por: Otasevic, V., et al.
Publicado: (2022)

PB2268: PAX5 ABERRANT EXPRESSION INCORPORATED IN MIPI-SP RISK SCORING SYSTEM EXHIBITS ADDITIVE VALUE IN MANTLE CELL LYMPHOMA
por: Zhang, Xin, et al.
Publicado: (2023)

PB2259: MONOCYTE’S INVOLVEMENT IN INFLAMMATORY RESPONSE IN COVID-19 INFECTION IN CHRONIC RENAL DISEASE
por: Bumbea, V., et al.
Publicado: (2022)

PB2402: CLINICAL CHARACTERISTICSAND PROGNOSIS RISK FACTORS OF NON-HODGKIN’S LYMPHOMA INVOLVING THE HEART
por: Chen, Yue, et al.
Publicado: (2023)

PB2347: THE ROLE OF UPFRONT LENALIDOMIDE MAINTENANCE FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS RESPONDING TO FIRST-LINE MTX TREATMENT
por: Zhang, Yan, et al.
Publicado: (2023)

Multisystem involvement of Langerhans cell histiocytosis in an adult
por: Samanci, Nilay Sengul, et al.
Publicado: (2019)

Striatal Involvement in Neurodegenerative Langerhans Cell Histiocytosis
por: de Haan, Sven, et al.
Publicado: (2019)

Langerhans Cell Histiocytosis with Uncommon Liver Involvement: A Case Report
por: Reginelli, Alfonso, et al.
Publicado: (2020)

Solitary Involvement of the Liver: A Rare Manifestation of Langerhans Cell Histiocytosis
por: Consing, Margarita, et al.
Publicado: (2022)

PB1769: STIM2, A CALCIUM CENSOR POTENTIALLY INVOLVED IN THE PATHOPHYSIOLOGY OF ACUTE MYELOID LEUKEMIA
por: Djordjevic, Stefan, et al.
Publicado: (2023)

PB1955: PROGNOSTIC VALUE OF SERUM CREATININE TO CYSTATIN C RATIO AND ESTABLISHMENT OF A NOVEL RISK SCORE MODEL IN CHRONIC LYMPHOCYTIC LEUKEMIA
por: Yin, Zixun, et al.
Publicado: (2023)

PB2123: MANAGEMENT OF PATIENTS WITH CONCOMITANT LIVER CIRRHOSIS AND AGGRESSIVE LYMPHOMA – A LITERATURE REVIEW
por: Jelicic, J., et al.
Publicado: (2022)

PB2065: SEVERE HEMOLYSIS OF PNH PATIENTS ASSOCIATED WITH OMICRON INFECTION IN CHINA
por: Yang, Hui, et al.
Publicado: (2023)

PB2496: CAR-T CELLS THERAPY COMBINED WITH POMALIDOMIDE AGAINST RELAPSE AND REFRACTORY MM OR ALL WITH EXTRAMEDULLARY INVOLVEMENT
por: Zhao, Jie, et al.
Publicado: (2023)

PB2338: BONE MARROW INVOLVEMENT IN KOREAN PATIENTS WITH LYMPHOMAS: A 21-YEAR LARGE SINGLE-CENTER STUDY: Keywords: Lymphoma, Bone marrow involvement
por: Kim, Min-Sun, et al.
Publicado: (2023)

PB2252: TREATMENT OF ANEMIA IN PATIENTS WITH GASTROINTESTINAL AND CHRONIC LIVER DISORDERS BASED ON PREDOMINANT PATHOGENETIC FACTOR.
por: Rybina, O., et al.
Publicado: (2022)

PB2409: CLINICAL PROGNOSTIC MODEL OF LIVER FAILURE AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Qu, Qingyuan, et al.
Publicado: (2023)

PB2130: RATIONAL FOR METHOTREXATE USAGE FOR THE TREATMENT AND PREVENTION OF CNS INVOLVEMENT IN PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMAS.
por: Misyurina, A., et al.
Publicado: (2022)

Langerhans cell histiocytosis
por: Aruna, D. R., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ak93farkasuvdvg3mi78en5bph